An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

NCT01885078 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2877

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Baricitinib
DRUG: Placebo

Sponsor

Eli Lilly and Company